CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
688426 Jiangsu Cowin Biotech
- 18.80
- +1.15+6.52%
Market Closed Apr 30 15:00 CST
2.11BMarket Cap-14.01P/E (TTM)
19.24High17.65Low19.73KlotVolume17.65Open17.65Pre Close36.87MTurnover5.19%Turnover RatioLossP/E (Static)112.49MShares32.0652wk High1.47P/B714.27MFloat Cap14.6452wk Low21.18Limit Up37.99MShs Float47.32Historical High14.12Limit Down9.01%Amplitude14.02Historical Low--Dividend TTM18.69Avg Price7.33KlotAsk--Div YieldTTM100Lot Size11.58KlotBid
Jiangsu Cowin Biotech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 49.31%43.01M | -26.54%125.88M | -35.11%98.28M | -44.76%67.15M | -62.57%28.8M | -67.15%171.34M | -61.94%151.45M | -54.23%121.56M | -37.35%76.94M | 54.11%521.6M |
| Operating revenue | 49.31%43.01M | -26.54%125.88M | -35.11%98.28M | -44.76%67.15M | -62.57%28.8M | -67.15%171.34M | -61.94%151.45M | -54.23%121.56M | -37.35%76.94M | 54.11%521.6M |
| Total operating cost | 16.16%74.39M | 3.67%283.52M | 5.30%207.56M | -0.46%131.78M | -8.12%64.04M | -15.94%273.47M | -10.49%197.11M | -9.14%132.39M | -8.34%69.69M | 56.67%325.31M |
| Operating cost | 74.89%21.21M | -8.48%55.48M | -18.95%35.82M | -34.45%23.9M | -46.83%12.13M | -61.38%60.61M | -57.35%44.19M | -50.85%36.46M | -42.26%22.81M | 67.63%156.96M |
| Operating tax surcharges | -5.40%518.12K | 119.63%2.62M | 230.46%2.09M | 346.50%1.2M | 374.54%547.72K | -1.58%1.19M | -30.58%633.85K | -62.41%268.83K | -64.44%115.42K | 17.14%1.21M |
| Operating expense | 3.58%18.66M | 11.26%79.56M | 6.93%57.05M | 9.85%37.44M | 25.14%18.02M | 21.89%71.51M | 29.13%53.35M | 26.22%34.08M | 5.00%14.4M | 42.78%58.66M |
| Administration expense | 0.36%12.71M | -16.34%51.69M | 0.23%44.84M | -2.10%26.93M | -2.80%12.67M | 49.71%61.79M | 33.41%44.73M | 50.84%27.5M | 61.43%13.03M | 35.18%41.27M |
| Financial expense | 106.05%98.09K | 48.78%-5.07M | 53.42%-4.29M | 52.16%-3.7M | -22.02%-1.62M | -45.37%-9.89M | -80.27%-9.21M | -165.56%-7.74M | -285.46%-1.33M | -345.71%-6.81M |
| -Interest expense (Financial expense) | -22.98%266.64K | -17.72%1.39M | -17.36%1.07M | -18.94%712.96K | --346.21K | -12.18%1.7M | -8.16%1.3M | -6.45%879.54K | ---- | 0.66%1.93M |
| -Interest Income (Financial expense) | 86.88%-262.04K | 45.16%-6.1M | 37.83%-5.81M | 42.88%-4.35M | ---2M | -300.50%-11.13M | -3,795.34%-9.34M | -2,030.79%-7.61M | ---- | -631.25%-2.78M |
| Research and development | -4.99%21.19M | 12.43%99.23M | 13.62%72.05M | 10.05%46.02M | 17.13%22.3M | 19.24%88.26M | 38.02%63.41M | 46.78%41.82M | 38.86%19.04M | 91.83%74.02M |
| Credit Impairment Loss | 86.40%-494.46K | -4.20%-21.67M | -2,019.02%-10.12M | -1,100.04%-5.03M | -322.84%-3.64M | -118.64%-20.8M | 92.15%-477.37K | 92.19%-418.89K | 293.91%1.63M | -493.00%-9.51M |
| Asset Impairment Loss | 65.33%-129.31K | 11.14%-9.64M | -94.07%-1.98M | -13.90%-1.16M | ---373.01K | -195.73%-10.85M | -18.18%-1.02M | -18.18%-1.02M | ---- | -203.27%-3.67M |
| Other net revenue | ||||||||||
| Fair value change income | 55,826.27%1.81M | -73.12%3.6M | -82.04%2.49M | -87.76%1.01M | -99.95%3.24K | 741.83%13.41M | 19,930.20%13.89M | 11,858.16%8.29M | 2,536.89%6.92M | 279.97%1.59M |
| Invest income | -50.85%3.02M | 9.84%14.61M | 134.52%11M | 145.48%9.29M | 391.53%6.14M | 109.39%13.3M | 8.51%4.69M | 9.85%3.79M | -19.00%1.25M | -11.15%6.35M |
| Asset deal income | ---9.76K | -85.02%185.41K | 105.53%57.12K | 367.59%55.91K | ---- | 340.98%1.24M | ---1.03M | --11.96K | ---- | -139.75%-513.74K |
| Other revenue | -24.47%1.44M | -0.88%6.71M | -41.82%3.06M | 121.17%2.81M | 80.73%1.9M | 20.95%6.77M | 43.35%5.25M | -19.33%1.27M | 316.03%1.05M | -30.24%5.6M |
| Operating profit | 17.47%-25.75M | -65.41%-163.84M | -330.07%-104.75M | -5,367.41%-57.64M | -289.42%-31.19M | -150.50%-99.05M | -113.62%-24.36M | -99.08%1.09M | -64.83%16.47M | 35.36%196.13M |
| Add:Non operating Income | -99.40%660 | -83.30%1.04M | 371.41%73.34K | 329.43%72.8K | 677.05%110.71K | 1,418,096.26%6.23M | 42.39%15.56K | 90.06%16.95K | --14.25K | -97.20%439 |
| Less:Non operating expense | --18.76K | 1,132.15%1.9M | 666.26%264.18K | 112,486.77%197.81K | ---- | -79.03%154.14K | -77.32%34.48K | -99.77%175.7 | ---- | 92.65%735.12K |
| Total profit | 17.11%-25.76M | -77.13%-164.7M | -330.52%-104.94M | -5,299.12%-57.77M | -288.58%-31.08M | -147.59%-92.98M | -113.64%-24.38M | -99.06%1.11M | -64.80%16.48M | 35.20%195.4M |
| Less:Income tax cost | -114.09%-2.9M | 63.97%-3.33M | -259.43%-9.04M | -241.72%-7.76M | -119.41%-1.35M | -137.22%-9.24M | -80.28%5.67M | -69.15%5.47M | -12.17%6.98M | 32.89%24.82M |
| Net profit | 23.09%-22.86M | -92.70%-161.38M | -219.23%-95.91M | -1,046.05%-50.01M | -412.83%-29.73M | -149.10%-83.74M | -120.03%-30.04M | -104.32%-4.36M | -75.56%9.5M | 35.54%170.57M |
| Net profit from continuing operation | 23.09%-22.86M | -96.37%-164.45M | -219.23%-95.91M | -1,046.05%-50.01M | -412.83%-29.73M | -149.10%-83.74M | -120.03%-30.04M | -104.32%-4.36M | -75.56%9.5M | 35.54%170.57M |
| Less:Minority Profit | 84.16%-120.73K | -725.75%-4.17M | -104.66%-256.28K | -99.11%49.11K | -113.82%-762.13K | -94.12%665.83K | 16.52%5.5M | 545.79%5.51M | 136,870.62%5.51M | --11.31M |
| Net profit of parent company owners | 21.49%-22.74M | -86.25%-157.21M | -169.09%-95.65M | -406.98%-50.06M | -826.10%-28.97M | -153.00%-84.41M | -124.47%-35.55M | -109.87%-9.87M | -89.74%3.99M | 26.55%159.26M |
| Earning per share | ||||||||||
| Basic earning per share | 19.23%-0.21 | -88.03%-1.414 | -138.89%-0.86 | -321.70%-0.447 | -750.00%-0.26 | -143.67%-0.752 | -117.31%-0.36 | -107.40%-0.106 | -93.55%0.04 | -4.33%1.722 |
| Diluted earning per share | 19.23%-0.21 | -88.37%-1.409 | -145.71%-0.86 | -324.76%-0.446 | -750.00%-0.26 | -143.62%-0.748 | -116.83%-0.35 | -107.37%-0.105 | -93.44%0.04 | -4.19%1.715 |
| Other composite income | -1.34%565.33 | -29.24%25.3K | -99.03%5.96K | -98.82%1.42K | 100.18%572.98 | -81.41%35.76K | 126.29%617.43K | -22.72%120.92K | -2,079.12%-320.89K | 1,691.52%192.31K |
| Other composite income of parent company owners | -1.34%565.33 | -29.24%25.3K | -99.03%5.96K | -98.82%1.42K | --572.98 | -81.41%35.76K | 126.29%617.43K | --120.92K | ---- | 1,691.52%192.31K |
| Total composite income | 23.09%-22.86M | -92.75%-161.35M | -225.91%-95.9M | -1,078.68%-50.01M | -423.75%-29.73M | -149.02%-83.71M | -119.58%-29.43M | -104.20%-4.24M | -76.37%9.18M | 35.71%170.77M |
| Total composite income of parent company owners | 21.49%-22.74M | -86.29%-157.18M | ---- | -413.25%-50.06M | -889.60%-28.97M | -152.92%-84.37M | ---- | -109.73%-9.75M | -90.56%3.67M | 26.71%159.45M |
| Total composite income of minority owners | 84.16%-120.73K | -725.75%-4.17M | ---- | -99.11%49.11K | -113.82%-762.13K | -94.12%665.83K | ---- | 545.79%5.51M | 136,870.62%5.51M | --11.31M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
| Auditor | -- | -- | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.